These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 25755719)
21. The Expression Status and Prognostic Value of Cancer Stem Cell Biomarker CD133 in Cutaneous Squamous Cell Carcinoma. Xu R; Cai MY; Luo RZ; Tian X; Han JD; Chen MK JAMA Dermatol; 2016 Mar; 152(3):305-11. PubMed ID: 26560495 [TBL] [Abstract][Full Text] [Related]
22. Clinicopathological significance of aberrant Notch receptors in intrahepatic cholangiocarcinoma. Wu WR; Shi XD; Zhang R; Zhu MS; Xu LB; Yu XH; Zeng H; Wang J; Liu C Int J Clin Exp Pathol; 2014; 7(6):3272-9. PubMed ID: 25031748 [TBL] [Abstract][Full Text] [Related]
23. DMBT1 expression in biliary carcinogenesis with correlation of clinicopathological data. Goeppert B; Roessler S; Becker N; Zucknick M; Vogel MN; Warth A; Pathil-Warth A; Mehrabi A; Schirmacher P; Mollenhauer J; Renner M Histopathology; 2017 Jun; 70(7):1064-1071. PubMed ID: 28130841 [TBL] [Abstract][Full Text] [Related]
24. Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients. Reggiani Bonetti L; Migaldi M; Caredda E; Boninsegna A; Ponz De Leon M; Di Gregorio C; Barresi V; Scannone D; Danese S; Cittadini A; Sgambato A Scand J Gastroenterol; 2012 Oct; 47(10):1211-7. PubMed ID: 22856425 [TBL] [Abstract][Full Text] [Related]
25. Epithelial cell adhesion molecule is a prognosis marker for intrahepatic cholangiocarcinoma. Sulpice L; Rayar M; Turlin B; Boucher E; Bellaud P; Desille M; Meunier B; Clément B; Boudjema K; Coulouarn C J Surg Res; 2014 Nov; 192(1):117-23. PubMed ID: 24909871 [TBL] [Abstract][Full Text] [Related]
26. Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma. Zhao P; Lu Y; Liu L Int J Clin Exp Pathol; 2015; 8(5):5230-5. PubMed ID: 26191222 [TBL] [Abstract][Full Text] [Related]
27. CD133 expression is correlated with poor prognosis in colorectal cancer. Kashihara H; Shimada M; Kurita N; Iwata T; Sato H; Kozo Yoshikawa ; Higashijima J; Chikakiyo M; Nishi M; Matsumoto N Hepatogastroenterology; 2014 Sep; 61(134):1563-7. PubMed ID: 25436343 [TBL] [Abstract][Full Text] [Related]
28. Investigation of diagnostic utility and expression profiles of stem cell markers (CD133 and CD90) in hepatocellular carcinoma, small cell dysplasia, and cirrhosis. Yilmaz G; Akyol G; Cakir A; Ilhan M Pathol Res Pract; 2014 Jul; 210(7):419-25. PubMed ID: 24702884 [TBL] [Abstract][Full Text] [Related]
29. Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression Of Gallbladder Adenocarcinoma. Jiang S; Pei L; Yang ZL; Liu G Hepatogastroenterology; 2014 May; 61(131):574-9. PubMed ID: 26176038 [TBL] [Abstract][Full Text] [Related]
30. Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis. Thonsri U; Seubwai W; Waraasawapati S; Sawanyawisuth K; Vaeteewoottacharn K; Boonmars T; Cha'on U Histol Histopathol; 2017 May; 32(5):503-510. PubMed ID: 27615379 [TBL] [Abstract][Full Text] [Related]
31. Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma. Matsushima H; Kuroki T; Kitasato A; Adachi T; Tanaka T; Hirabaru M; Hirayama T; Kuroshima N; Hidaka M; Soyama A; Takatsuki M; Kinoshita N; Sano K; Nishida N; Eguchi S Dig Liver Dis; 2015 Dec; 47(12):1067-75. PubMed ID: 26341967 [TBL] [Abstract][Full Text] [Related]
32. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis. Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734 [TBL] [Abstract][Full Text] [Related]
33. AC133 expression associated with poor prognosis in stage II colorectal cancer. Ying X; Wu J; Meng X; Zuo Y; Xia Q; Chen J; Feng Y; Liu R; Li L; Huang W Med Oncol; 2013 Mar; 30(1):356. PubMed ID: 23322518 [TBL] [Abstract][Full Text] [Related]
34. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma. Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275 [TBL] [Abstract][Full Text] [Related]
35. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals. Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186 [TBL] [Abstract][Full Text] [Related]
36. Correlation and prognostic significance of MMP-2 and TFPI-2 differential expression in pancreatic carcinoma. Zhai LL; Cai CY; Wu Y; Tang ZG Int J Clin Exp Pathol; 2015; 8(1):682-91. PubMed ID: 25755762 [TBL] [Abstract][Full Text] [Related]
38. Characterization of CD133+ parenchymal cells in the liver: histology and culture. Yoshikawa S; Zen Y; Fujii T; Sato Y; Ohta T; Aoyagi Y; Nakanuma Y World J Gastroenterol; 2009 Oct; 15(39):4896-906. PubMed ID: 19842219 [TBL] [Abstract][Full Text] [Related]
39. Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma. Zhou L; He XD; Cui QC; Zhou WX; Qu Q; Zhou RL; Rui JA; Yu JC Cancer Lett; 2008 Jun; 264(2):209-17. PubMed ID: 18334282 [TBL] [Abstract][Full Text] [Related]
40. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer. Kapucuoğlu N; Bozkurt KK; Başpınar Ş; Koçer M; Eroğlu HE; Akdeniz R; Akçil M Pathol Res Pract; 2015 Oct; 211(10):740-7. PubMed ID: 26298632 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]